1. Brain monoamines and parkinsonism;Hornykiewicz;Natl. Inst. Drug Abuse Res. Monogr. Ser.,1975
2. Der L-2,3-Dioxyphenylalanin (L-Dopa)-Effekt bei der. Parkinson-Akinese;Birkmayer;Klin. Wschr.,1961
3. Aromatic amino acids and modification of parkinsonism;Cotzias;N. Engl. J. Med.,1967
4. Poewe, W., and Granata, R.1997. Pharmacological treatment of Parkinson's disease. In Movement Disorders: Neurological Principles and PracticeR. L. Watts and W. C. Koller, Eds., pp. 201–220. McGraw-Hill, New York.
5. Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression;Lo;Hum. Gene Ther.,1999